İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2014 · article

Management of brain metastases from non small cell lung cancer

YÖKSİS OpenAlex Açık erişim · diamond
Yıl2014
Atıf25OpenAlex
Yüzdelik%86,8
FWCI2,01,00 = dünya ortalaması
Scopus (SJR)Q3
WoS (JCR)Q4

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıJournal of Cancer Research and Therapeutics
  • Katalog eşleşmesi (ISSN)Journal of Cancer Research and Therapeutics
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

OpenAlex İngilizce

PURPOSE: The purpose of the following study is to evaluate the treatment modalities, clinical status and prognostic factors affecting survival rates in patients with newly diagnosed brain metastasis from non-small cell lung cancer (NSCLC). PATIENTS AND METHODS: NSCLC patients with a new diagnosis of one to four brain metastasis evaluated retrospectively for the effects of treatment regimens on local failure-relapse-free survival (LRFS) and overall survival (OS). The relationship between age, gender, performance status, recursive partitioning analysis (RPA) classification, the primary tumor under control, number of metastatic tumors in the brain and total volume of brain metastasis and prognosis is analyzed. RESULTS: Out of a total of 138 (121 male and 17 female) patients, nearly 44.2% received only gamma-knife (GK); 24.6% were received both GK and whole brain radiotherapy (WBRT), 2.9% had GK and surgery, 3.6% received GK, surgery and WBRT, 10.9% had surgery and WBRT and 12.3% received only WBRT for treatment. Median LRFS of surgery plus WBRT group was significantly higher when compared with WBRT group (P<0.0001). The OS was significantly longer for surgery plus WBRT group than the other treatment groups (P=0.037). When median survival of WBRT-only group compared with surgery plus WBRT, it was significantly higher (29.6 months vs. 16.7 months, P=0.006). Median OS of surgery plus WBRT group was significantly higher than GK plus WBRT group (29.6 months vs. 9.3 months, P=0.007). CONCLUSION: WBRT is still the most effective treatment method following surgery in selected patients according to their age, performance status and spread of the primary disease with NSCLC had limited number brain metastasis. Adding WBRT treatment after surgery significantly improved OS and LRFS.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

25atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 2 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2022 Surgical Management and Postoperative Outcome in patients with Brain Metastases: Our Surgical ExperienceAtıf 1 · OpenAlex
  2. 2020 Analysis of survival of patients with brain metastases according to prognostic indexes and treatment strategiesAtıf 1 · OpenAlex

Yazarlar

10
  1. MELTEM BAYKARA 1
  2. GÖKHAN KURT 2
  3. SÜLEYMAN BÜYÜKBERBER 3
  4. UMUT DEMİRCİ 4
  5. necdet çeviker 5
  6. efnan algin 6
  7. UĞUR COŞKUN GAZİ ÜNİVERSİTESİ 7
  8. şükrü aykol 8
  9. AHMET ÖZET GAZİ ÜNİVERSİTESİ 9
  10. MUSTAFA BENEKLİ 10